|
시장보고서
상품코드
2050507
경장영양제 시장 : 제품별, 플로우 유형별, 단계별, 적응증별, 최종 용도별, 판매 채널별, 지역별Enteral Feeding Formulas Market, By Product, By Flow Type, By Stage, By Indication, By End Use, By Sales Channel, By Geography |
||||||
경장영양제 시장은 2026년에 76억 1,000만 달러로 추계되고 있으며, 2033년까지 145억 6,000만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에 CAGR 9.7%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 76억 1,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 9.70% | 2033년 시장 규모 예측 : | 145억 6,000만 달러 |
경장영양제는 충분한 경구 섭취가 어려운 분들을 위해 위, 십이지장 또는 공복에 직접 투여하는 영양 보조 식품입니다. 경장영양제에는 다양한 유형이 있습니다. 단백질 기반 제제는 단백질을 주성분으로 하며, 영양 지원이 필요하거나 탄수화물과 지방 섭취를 최소화해야 하는 사람들에게 사용됩니다. 표준 제형은 탄수화물, 단백질, 지방의 균형 잡힌 배합으로 구성되어 있습니다. 이들은 일상적인 영양 요구의 대부분을 충족시키고 장기적으로 사용하기에 적합합니다. 질병 특이적 제제는 당뇨병, 신부전, 간질환 등 특정 건강 상태에 맞춰져 있습니다. 식이섬유 함유 제제는 수용성 및 불용성 식이섬유를 제공하여 정상적인 장 활동을 촉진합니다.
각 유형의 영양제에는 각각 장단점이 있습니다. 단백질 기반 영양제는 과도한 칼로리 섭취 없이 단백질 필요량을 충족시키는 데 도움이 되지만, 영양 균형이 부족합니다. 표준 영양제는 균형 잡힌 영양을 제공하지만, 특별한 식단 요구 사항을 충족시키지 못할 수 있습니다. 질병 특이적 영양제는 특정 질병에 특화된 영양 요구 사항을 충족시키지만, 비용이 더 많이 듭니다. 식이섬유 함유 포뮬러는 규칙적인 배변을 돕고, 점도가 높으며, 칼로리도 높습니다. 적절한 포뮬러는 개인의 건강 상태, 영양 요구 사항 및 내약성에 따라 선택해야 합니다. 경장영양은 경구 섭취를 통해 영양을 섭취할 수 없는 환자에게 충분한 영양을 안정적으로 공급합니다.
시장 역학
세계의 경장영양제 시장은 고령 인구 증가, 만성질환 유병률 증가, 미숙아 출산율 증가, 성인 연하장애 환자 급증 등으로 인해 성장세를 보이고 있습니다. 유엔의 예측에 따르면 60세 이상 인구는 2050년까지 거의 두 배로 증가하여 젊은 층의 인구를 넘어설 것으로 예상됩니다. 노인들은 치매, 수술 후 합병증 등 경장영양 지원이 필요한 상태에 놓이기 쉬운 경향이 있습니다. 또한 암, 신경질환, 소화기 질환 등 만성질환으로 인해 경장영양제를 필요로 하는 사례가 전 세계에서 증가하고 있습니다. 이는 시장 성장에 긍정적인 영향을 미치고 있습니다. 그러나 대체 영양 섭취 방법의 존재, 튜브와 관련된 감염 위험 및 특수 영양제의 높은 비용으로 인해 시장 성장이 제한되고 있습니다. 유기농, 비유전자변형(Non-GMO) 및 알레르겐이 없는 영양제 개발은 시장 관계자들에게 유망한 비즈니스 기회가 되고 있습니다.
본 조사의 주요 특징
- 이 조사에서는 각 부문의 잠재적 매출 성장 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요 인사이트를 제공합니다.
- 이 연구는 다음과 같은 매개 변수를 기반으로 세계의 경장영양제 시장의 주요 기업 개요을 작성했습니다. 구체적으로 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적 및 전략 등입니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 유형 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것으로 기대됩니다.
- 세계의 장내 영양제 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 글로벌 경장영양제 시장 분석에 사용되는 다양한 전략 매트릭스를 활용하여 의사결정을 원활하게 할 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 경장영양제 시장 : 제품별, 2021-2033년
제5장 세계의 경장영양제 시장 : 플로우 유형별, 2021-2033년
제6장 세계의 경장영양제 시장 : 단계별, 2021-2033년
제7장 세계의 경장영양제 시장 : 적응증별, 2021-2033년
제8장 세계의 경장영양제 시장 : 최종사용자별, 2021-2033년
제9장 세계의 경장영양제 시장 : 판매 채널별, 2021-2033년
제10장 세계의 경장영양제 시장 : 지역별, 2021-2033년
제11장 경쟁 구도
제12장 섹션
KSA 26.06.10Enteral Feeding Formulas Market is estimated to be valued at USD 7.61 Bn in 2026 and is expected to reach USD 14.56 Bn by 2033, growing at a compound annual growth rate (CAGR) of 9.7%USD 14.56 Bn from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 7.61 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 9.70% | 2033 Value Projection: | USD 14.56 Bn |
Enteral feeding formulas are nutritional supplements that are administered directly into the stomach, duodenum, or jejunum of individuals who cannot obtain adequate oral intake. There are different types of enteral feeding formulas available. Protein-based formulas contain protein as the main nutrient and are used for individuals who need nutrition support but minimal carbohydrate or fat intake. Standard formulas provide a balanced proportion of carbohydrates, proteins, and fats. They meet most daily nutritional needs and are suitable for long-term use. Disease-specific formulas are tailored for certain health conditions like diabetes, renal failure, or liver disease. Fiber-containing formulas provide soluble and insoluble fiber to promote normal bowel function.
Each type of formula has its own advantages and disadvantages. Protein-based formulas help meet protein needs without excess calories but lack balanced nutrition. Standard formulas provide balanced nutrition but may not meet special dietary needs. Disease-specific formulas address the unique nutritional requirements of certain illnesses but come at a higher cost. Fiber-containing formulas aid in regular bowel movements but have a thicker consistency and higher calorie content. The appropriate formula must be selected based on the individual's health status, nutritional requirements, and tolerateability. Enteral feeding ensures adequate nutrition in patients who cannot obtain nutrition through oral intake.
Market Dynamics
The global enteral feeding formulas market is driven by the rising geriatric population, increasing incidence of chronic diseases, growing number of preterm births, and surging cases of dysphagia among adults. As per UN projections, the population aged 60 years and above will nearly double by 2050 and become larger than the youth population. The aged people is more prone to conditions requiring enteral feeding assistance like dementia and complications post-surgery. Additionally, chronic diseases like cancer, neurological disorders, and gastrointestinal illnesses, necessitating enteral nutrition aids are on the rise internationally. This is positively impacting the market growth. However, the availability of alternative delivery methods, risk of infections associated with tubes, and high costs of specialized formulas are restraining the market growth. The development of organic, non-GMO (non-genetically modified organisms), and allergen-free formulas presents lucrative opportunities for market players.
Key Features of the Study
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global enteral feeding formulas market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Nestle, VICTUS, Primus Pharmaceuticals, Inc., Meiji Holdings. Co., Ltd., Mead Johnson & Company, LLC, Abbott, Danone S.A, and Fresenius Kabi AG.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global enteral feeding formulas market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global enteral feeding formulas market.
Market Segmentation
- By Product (Revenue, USD Bn, 2021 - 2033)
- Standard Formula
- Disease-specific Formulas
- Elemental Formulas
- Specialized Formulas
- By Flow Type (Revenue, USD Bn, 2021 - 2033)
- Intermittent Feeding Flow
- Continuous Feeding Flow
- By Stage (Revenue, USD Bn, 2021 - 2033)
- Adults
- Pediatrics
- By Indication (Revenue, USD Bn, 2021 - 2033)
- Alzheimer's
- Nutrition Deficiency
- Cancer Care
- Diabetes
- Chronic Kidney Diseases
- Orphan Diseases
- Dysphagia
- Pain Management
- Others (Malabsorption/GI Disorder/Diarrhea, etc.)
- By End Use (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Cardiology
- Neurology
- Critical Care (ICU)
- Oncology
- Others
- Home Care
- By Sales Channel (Revenue, USD Bn, 2021 - 2033)
- Online Sales
- Retail Sales
- Institutional Sales
- By Region (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Companies
- Nestle
- VICTUS
- Primus Pharmaceuticals, Inc.
- Meiji Holdings. Co., Ltd.
- Mead Johnson & Company, LLC
- Abbott
- Danone S.A
- Fresenius Kabi AG
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Enteral Feeding Formulas Market, By Product
- Global Enteral Feeding Formulas Market, By Flow Type
- Global Enteral Feeding Formulas Market, By Stage
- Global Enteral Feeding Formulas Market, By Indication
- Global Enteral Feeding Formulas Market, By End User
- Global Enteral Feeding Formulas Market, By Sales Channel
- Global Enteral Feeding Formulas Market, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Rising incidence of chronic diseases
- Changes in healthcare landscape and reimbursement policies
- Increasing preference for homecare services
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Service offering Portfolio
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Pipeline Analysis
4. Global Enteral Feeding Formulas Market, By Product, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Standard Formula
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
- Disease-specific Formulas
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
- Elemental Formulas
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
- Specialized Formulas
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
5. Global Enteral Feeding Formulas Market, By Flow Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Intermittent Feeding Flow
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
- Continuous Feeding Flow
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
6. Global Enteral Feeding Formulas Market, By Stage, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Adults
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
- Pediatrics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
7. Global Enteral Feeding Formulas Market, By Indication, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Alzheimer's
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
- Nutrition Deficiency
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
- Cancer Care
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
- Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
- Chronic Kidney Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
- Orphan Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
- Dysphagia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
- Pain Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
- Others (Malabsorption/GI Disorder/Diarrhea, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
8. Global Enteral Feeding Formulas Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
- Cardiology
- Neurology
- Critical Care (ICU)
- Oncology
- Others
- Home Care
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
9. Global Enteral Feeding Formulas Market, By Sales Channel, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Online Sales
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
- Retail Sales
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
- Institutional Sales
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
10. Global Enteral Feeding Formulas Market, By Region, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Flow Type, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Stage, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Flow Type, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Stage, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Flow Type, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Stage, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Flow Type, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Stage, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Flow Type, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Stage, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Flow Type, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Stage, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2021 - 2033,(USD Bn)
- North Africa
- Central Africa
- South Africa
11. Competitive Landscape
- Nestle
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- VICTUS
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Primus Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Meiji Holdings. Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Mead Johnson & Company, LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Abbott
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Danone S.A
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Fresenius Kabi AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
12. Section
- Research Methodology
- About us
